India’s Bharat Biotech says its Covaxin booster dose offers long term protection – Reuters India

Jan 8 (Reuters) – India’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.

The company said a booster dose was given to trial participants six months after they received their second dose.

Register now for FREE unlimited access to Reuters.com

Reporting by Rhea Binoy in Bengaluru; Editing by Toby Chopra

Our Standards: The Thomson Reuters Trust Principles.

Sorgente articolo:
India’s Bharat Biotech says its Covaxin booster dose offers long term protection – Reuters India

User ID Campaign ID Link
d9a95efa0a2845057476957a427b0499 l-99999994 Email Marketing
d9a95efa0a2845057476957a427b0499 l-99999996 Service for LMS
d9a95efa0a2845057476957a427b0499 l-99999993 High Pagerank Service
d9a95efa0a2845057476957a427b0499 l-99999984 Free Web Hosting